New York City, NY -- (SBWIRE) -- 12/23/2013 -- StockMarketIntel.com issues a special report on the following stocks: AuRico Gold Inc (NYSE:AUQ), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), LinnCo LLC (NASDAQ:LNCO), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN).
AuRico Gold Inc (NYSE:AUQ) ended its recent business day with the advanced of 0.29% and closed at the price of $3.42 after opening at $3.42. The stock traded during its last trading session with the total volume of 4.57 million shares, as compared to its average volume of 2.03 million shares. AuRico Gold Inc. operates as a gold producer with mines and projects in North America. The company’s core operations include the Young-Davidson gold mine in Northern Ontario, Canada; and the El Chanate mine in Sonora State, Mexico.
Will AUQ Continue To Move Higher? Find out via this report
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) remained among the day bullish 0.25% and traded with volume of 6.94 million shares in the last session, as compared to average volume of 1.00 million shares. In comparison with 52 week range of $1.49 - $5.95, it faced lowest price of $3.96 during the last trading session whereas its day highest price was $4.09. The company’s total market capitalization is $391.93 million, along with 97.98 million shares outstanding. ZIOPHARM Oncology, Inc., a biopharmaceutical company, focuses on the discovery and development of new cancer therapies.
Will ZIOP Continue To Move Higher? Find out via this report
LinnCo LLC (NASDAQ:LNCO) showed 4.36 million shares in volume during the last trading session, while the average trading volume remained 1.13 million shares. The stock kicked off its trading session at $29.50 and closed at $29.62 after rallied 2.10%. Linn Co, LLC, through its limited liability company interests in Linn Energy, LLC, focuses on the acquisition and development of oil and natural gas properties in the United States.
Why Should Investors Buy LNCO After The Recent Gain? Just Go Here and Find Out
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock traded during its last trading session with the total traded volume of 6.39 million shares versus its average volume of 2.14 million shares. The company opened its trade at the price of $3.14 and its closing price was $3.13 stock not showed any percentage change and stayed at 0.00% for the day. Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally.
Can Investors Bet on ACHN after this News update? Find out in this Research Report
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)